VA declines broad coverage for new J&J depression drug touted by Trump - STAT

VA declines broad coverage for new J&J depression drug touted by Trump  STATMany experts have embraced the medication, known as esketamine, but some watchdog groups have expressed concerns about its effectiveness and safety.